167 related articles for article (PubMed ID: 12566902)
1. Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin.
Joerger M; Oehlschlegel C; Cerny T; Gillessen S
Onkologie; 2002 Dec; 25(6):558-61. PubMed ID: 12566902
[TBL] [Abstract][Full Text] [Related]
2. Postradiation prostatic sarcoma: de novo carcinogenesis or dedifferentiation of prostatic adenocarcinoma?
Canfield SE; Gans TH; Unger P; Hall SJ
Tech Urol; 2001 Dec; 7(4):294-5. PubMed ID: 11763492
[TBL] [Abstract][Full Text] [Related]
3. High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.
Fuller DB; Wurzer J; Shirazi R; Bridge SS; Law J; Mardirossian G
Pract Radiat Oncol; 2015; 5(6):e615-23. PubMed ID: 26059509
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced prostatic sarcoma: a case report.
Scully JM; Uno JM; McIntyre M; Mosely S
J Urol; 1990 Sep; 144(3):746-8. PubMed ID: 2388344
[TBL] [Abstract][Full Text] [Related]
5. Prostatic carcinosarcoma 15 years after combined external beam radiation and brachytherapy for prostatic adenocarcinoma: a case report.
Tseng TY; Sevilla DW; Moul JW; Maloney KE
Prostate Cancer Prostatic Dis; 2006; 9(2):195-7. PubMed ID: 16568146
[TBL] [Abstract][Full Text] [Related]
6. [Osteosarcoma of the prostate after radiotherapy].
Stangelberger A; Riedl CR; Susani M
Aktuelle Urol; 2012 Dec; 43(6):409-11. PubMed ID: 23196780
[TBL] [Abstract][Full Text] [Related]
7. Case records of the Massachusetts General Hospital. Case 5-2011. A 65-year-old man with hematuria after treatment for prostate cancer.
Kaufman DS; Zietman AL; Dahl DM; Harisinghani MG; Wu CL
N Engl J Med; 2011 Feb; 364(7):667-75. PubMed ID: 21323545
[No Abstract] [Full Text] [Related]
8. Embryonal rhabdomyosarcoma of the prostate.
Niimi K; Hashimoto Y; Kurokawa S; Okada A; Tozawa K; Kohri K
Int J Clin Oncol; 2010 Feb; 15(1):93-6. PubMed ID: 20087615
[TBL] [Abstract][Full Text] [Related]
9. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
10. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
[TBL] [Abstract][Full Text] [Related]
11. Prostatic sarcoma after conservative treatment with brachytherapy for low-risk prostate cancer.
Domínguez A; Piulats JM; Suárez JF; Condom E; Castells M; Camps N; García Del Muro FX; Franco E
Acta Oncol; 2013 Aug; 52(6):1215-6. PubMed ID: 23095143
[No Abstract] [Full Text] [Related]
12. [Appearance of carcinosarcoma after radiotherapy for local recurrence after radical prostatectomy. Case report and review of the literature].
Dallinger B; Würnschimmel E
Urologe A; 2010 Jun; 49(6):750-4. PubMed ID: 20237907
[TBL] [Abstract][Full Text] [Related]
13. Liposomal doxorubicin for the treatment of hormone-refractory prostate cancer.
Harris KA; Harney E; Small EJ
Clin Prostate Cancer; 2002 Jun; 1(1):37-41. PubMed ID: 15046711
[TBL] [Abstract][Full Text] [Related]
14. [Surveillance after prostate cancer radiotherapy].
Supiot S; Rio E; Clément-Colmou K; Bouchot O; Rigaud J
Cancer Radiother; 2011 Oct; 15(6-7):540-5. PubMed ID: 21795093
[TBL] [Abstract][Full Text] [Related]
15. Primary high-grade myofibroblastic sarcoma arising from the pericardium.
Koga S; Ikeda S; Urata J; Chijiwa R; Abe K; Hayashi T; Eishi K; Kohno S
Circ J; 2008 Feb; 72(2):337-9. PubMed ID: 18219177
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma of the prostate.
Mohan H; Bal A; Punia RP; Bawa AS
Int J Urol; 2003 Feb; 10(2):114-6. PubMed ID: 12588611
[TBL] [Abstract][Full Text] [Related]
17. Secondary spindle cell sarcoma following external beam radiotherapy for prostate cancer: a rare but devastating complication.
Farag M; Ta A; Shankar S; Wong LM
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30002213
[TBL] [Abstract][Full Text] [Related]
18. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
Mabjeesh NJ; Chen J; Stenger A; Matzkin H
Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
[TBL] [Abstract][Full Text] [Related]
19. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial.
Barkati M; Williams SG; Foroudi F; Tai KH; Chander S; van Dyk S; See A; Duchesne GM
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1889-96. PubMed ID: 21550182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
